Michel Legraverend
- Organic Chemistry top 5%
- Molecular Biology
- Infectious Diseases top 10%
- Oncology
- Physiology top 5%
- Co-authors
- David S. GriersonÉmile BisagniLaurent MeijerVirginie BrunRobert I. GlazerSandrine PiguelNada IbrahimPierre Ducrot
- Topics
- HIV/AIDS drug development and treatment (18 papers)Biochemical and Molecular Research (11 papers)Synthesis and Biological Evaluation (9 papers)
- Journals
- Nucleic Acids ResearchAnnals of the New York Academy of SciencesJournal of Medicinal Chemistry
- Partner nations
- FranceUnited States
In The Last Decade
Michel Legraverend
53 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Organic Chemistry 681
- Molecular Biology 591
- Infectious Diseases 220
- Oncology 172
- Physiology 82
Countries citing papers authored by Michel Legraverend
This map shows the geographic impact of Michel Legraverend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Legraverend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Legraverend more than expected).
Fields of papers citing papers by Michel Legraverend
This network shows the impact of papers produced by Michel Legraverend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Legraverend. The network helps show where Michel Legraverend may publish in the future.
Co-authorship network of co-authors of Michel Legraverend
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Legraverend. A scholar is included among the top collaborators of Michel Legraverend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Legraverend. Michel Legraverend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 13 | |
| 4 | 29 | |
| 5 | 16 | |
| 6 | 288 | |
| 7 | 17 | |
| 8 | 9 | |
| 9 | 8 | |
| 10 | 53 | |
| 11 | 3 | |
| 12 | 8 | |
| 13 | 3 | |
| 14 | 3 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | 8 | |
| 18 | 25 | |
| 19 | 2 | |
| 20 | Inhibition of the phosphorylation of non-histone chromosomal proteins of rat liver by cordycepin and cordycepin triphosphate. | 15 |
About Michel Legraverend
Michel Legraverend is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), Biochemical and Molecular Research (11 papers) and Synthesis and Biological Evaluation (9 papers). The work is most often cited by research in Organic Chemistry (681 citations), Physiology (82 citations) and Infectious Diseases (220 citations). Michel Legraverend has collaborated with scholars based in France and United States. Frequent co-authors include David S. Grierson, Émile Bisagni, Laurent Meijer, Virginie Brun, Robert I. Glazer, Sandrine Piguel, Nada Ibrahim, Pierre Ducrot, Sophie Leclerc and Anné-Marie Aubertin. Their work appears in journals such as Nucleic Acids Research, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.